299 related articles for article (PubMed ID: 31760463)
1. Molecular mechanism of olesoxime-mediated neuroprotection through targeting α-synuclein interaction with mitochondrial VDAC.
Rovini A; Gurnev PA; Beilina A; Queralt-Martín M; Rosencrans W; Cookson MR; Bezrukov SM; Rostovtseva TK
Cell Mol Life Sci; 2020 Sep; 77(18):3611-3626. PubMed ID: 31760463
[TBL] [Abstract][Full Text] [Related]
2. Restricting α-synuclein transport into mitochondria by inhibition of α-synuclein-VDAC complexation as a potential therapeutic target for Parkinson's disease treatment.
Rajendran M; Queralt-Martín M; Gurnev PA; Rosencrans WM; Rovini A; Jacobs D; Abrantes K; Hoogerheide DP; Bezrukov SM; Rostovtseva TK
Cell Mol Life Sci; 2022 Jun; 79(7):368. PubMed ID: 35718804
[TBL] [Abstract][Full Text] [Related]
3. α-Synuclein Shows High Affinity Interaction with Voltage-dependent Anion Channel, Suggesting Mechanisms of Mitochondrial Regulation and Toxicity in Parkinson Disease.
Rostovtseva TK; Gurnev PA; Protchenko O; Hoogerheide DP; Yap TL; Philpott CC; Lee JC; Bezrukov SM
J Biol Chem; 2015 Jul; 290(30):18467-77. PubMed ID: 26055708
[TBL] [Abstract][Full Text] [Related]
4. α-Synuclein emerges as a potent regulator of VDAC-facilitated calcium transport.
Rosencrans WM; Aguilella VM; Rostovtseva TK; Bezrukov SM
Cell Calcium; 2021 May; 95():102355. PubMed ID: 33578201
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Mitochondrial Respiration by VDAC Is Enhanced by Membrane-Bound Inhibitors with Disordered Polyanionic C-Terminal Domains.
Rostovtseva TK; Bezrukov SM; Hoogerheide DP
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298976
[TBL] [Abstract][Full Text] [Related]
6. Exploring lipid-dependent conformations of membrane-bound α-synuclein with the VDAC nanopore.
Hoogerheide DP; Rostovtseva TK; Bezrukov SM
Biochim Biophys Acta Biomembr; 2021 Sep; 1863(9):183643. PubMed ID: 33971161
[TBL] [Abstract][Full Text] [Related]
7. Modulation of the mitochondrial voltage dependent anion channel (VDAC) by curcumin.
Tewari D; Ahmed T; Chirasani VR; Singh PK; Maji SK; Senapati S; Bera AK
Biochim Biophys Acta; 2015 Jan; 1848(1 Pt A):151-8. PubMed ID: 25459681
[TBL] [Abstract][Full Text] [Related]
8. Alpha-Synuclein and Mitochondrial Dysfunction in Parkinson's Disease: The Emerging Role of VDAC.
Risiglione P; Zinghirino F; Di Rosa MC; Magrì A; Messina A
Biomolecules; 2021 May; 11(5):. PubMed ID: 34064816
[TBL] [Abstract][Full Text] [Related]
9. Targeting putative components of the mitochondrial permeability transition pore for novel therapeutics.
Winquist RJ; Gribkoff VK
Biochem Pharmacol; 2020 Jul; 177():113995. PubMed ID: 32339494
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effect of chondroitin sulfate on SH‑SY5Y cells overexpressing wild‑type or A53T mutant α‑synuclein.
Ju C; Gao J; Hou L; Wang L; Zhang F; Sun F; Zhang T; Xu P; Shi Z; Hu F; Zhang C
Mol Med Rep; 2017 Dec; 16(6):8721-8728. PubMed ID: 28990084
[TBL] [Abstract][Full Text] [Related]
11. Amyloid-β suppresses AMP-activated protein kinase (AMPK) signaling and contributes to α-synuclein-induced cytotoxicity.
Lin CL; Cheng YS; Li HH; Chiu PY; Chang YT; Ho YJ; Lai TJ
Exp Neurol; 2016 Jan; 275 Pt 1():84-98. PubMed ID: 26515689
[TBL] [Abstract][Full Text] [Related]
12. Sequence diversity of tubulin isotypes in regulation of the mitochondrial voltage-dependent anion channel.
Rostovtseva TK; Gurnev PA; Hoogerheide DP; Rovini A; Sirajuddin M; Bezrukov SM
J Biol Chem; 2018 Jul; 293(28):10949-10962. PubMed ID: 29777059
[TBL] [Abstract][Full Text] [Related]
13. Protective role of olesoxime against wild-type α-synuclein-induced toxicity in human neuronally differentiated SHSY-5Y cells.
Gouarné C; Tracz J; Paoli MG; Deluca V; Seimandi M; Tardif G; Xilouri M; Stefanis L; Bordet T; Pruss RM
Br J Pharmacol; 2015 Jan; 172(1):235-45. PubMed ID: 25220617
[TBL] [Abstract][Full Text] [Related]
14. The intrinsically disordered N-terminus of the voltage-dependent anion channel.
Preto J; Krimm I
PLoS Comput Biol; 2021 Feb; 17(2):e1008750. PubMed ID: 33577583
[TBL] [Abstract][Full Text] [Related]
15. The mitochondrial voltage-dependent anion channel 1 in tumor cells.
Shoshan-Barmatz V; Ben-Hail D; Admoni L; Krelin Y; Tripathi SS
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2547-75. PubMed ID: 25448878
[TBL] [Abstract][Full Text] [Related]
16. Oligomerization of the mitochondrial protein voltage-dependent anion channel is coupled to the induction of apoptosis.
Keinan N; Tyomkin D; Shoshan-Barmatz V
Mol Cell Biol; 2010 Dec; 30(24):5698-709. PubMed ID: 20937774
[TBL] [Abstract][Full Text] [Related]
17. ATP transport through VDAC and the VDAC-tubulin complex probed by equilibrium and nonequilibrium MD simulations.
Noskov SY; Rostovtseva TK; Bezrukov SM
Biochemistry; 2013 Dec; 52(51):9246-56. PubMed ID: 24245503
[TBL] [Abstract][Full Text] [Related]
18. Voltage-activated complexation of α-synuclein with three diverse β-barrel channels: VDAC, MspA, and α-hemolysin.
Hoogerheide DP; Gurnev PA; Rostovtseva TK; Bezrukov SM
Proteomics; 2022 Mar; 22(5-6):e2100060. PubMed ID: 34813679
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-7 Regulates the Function of Mitochondrial Permeability Transition Pore by Targeting VDAC1 Expression.
Chaudhuri AD; Choi DC; Kabaria S; Tran A; Junn E
J Biol Chem; 2016 Mar; 291(12):6483-93. PubMed ID: 26801612
[TBL] [Abstract][Full Text] [Related]
20. JNK activation and translocation to mitochondria mediates mitochondrial dysfunction and cell death induced by VDAC opening and sorafenib in hepatocarcinoma cells.
Heslop KA; Rovini A; Hunt EG; Fang D; Morris ME; Christie CF; Gooz MB; DeHart DN; Dang Y; Lemasters JJ; Maldonado EN
Biochem Pharmacol; 2020 Jan; 171():113728. PubMed ID: 31759978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
